Much more medicine for the oldest old: trends in UK electronic clinical records

David Melzer, Behrooz Tavakoly, Rachel E Winder, Jane A H Masoli, William E Henley, Alessandro Ble, Suzanne H Richards, David Melzer, Behrooz Tavakoly, Rachel E Winder, Jane A H Masoli, William E Henley, Alessandro Ble, Suzanne H Richards

Abstract

Background: the oldest old (85+) pose complex medical challenges. Both underdiagnosis and overdiagnosis are claimed in this group.

Objective: to estimate diagnosis, prescribing and hospital admission prevalence from 2003/4 to 2011/12, to monitor trends in medicalisation.

Design and setting: observational study of Clinical Practice Research Datalink (CPRD) electronic medical records from general practice populations (eligible; n = 27,109) with oversampling of the oldest old.

Methods: we identified 18 common diseases and five geriatric syndromes (dizziness, incontinence, skin ulcers, falls and fractures) from Read codes. We counted medications prescribed ≥1 time in all quarters of studied years.

Results: there were major increases in recorded prevalence of most conditions in the 85+ group, especially chronic kidney disease (stages 3-5: prevalence <1% rising to 36.4%). The proportions of the 85+ group with ≥3 conditions rose from 32.2 to 55.1% (27.1 to 35.1% in the 65-84 year group). Geriatric syndrome trends were less marked. In the 85+ age group the proportion receiving no chronically prescribed medications fell from 29.6 to 13.6%, while the proportion on ≥3 rose from 44.6 to 66.2%. The proportion of 85+ year olds with ≥1 hospital admissions per year rose from 27.6 to 35.4%.

Conclusions: there has been a dramatic increase in the medicalisation of the oldest old, evident in increased diagnosis (likely partly due to better record keeping) but also increased prescribing and hospitalisation. Diagnostic trends especially for chronic kidney disease may raise concerns about overdiagnosis. These findings provide new urgency to questions about the appropriateness of multiple diagnostic labelling.

Keywords: admission; kidney; older people; oldest; prescribing; prevalence.

© The Author 2014. Published by Oxford University Press on behalf of the British Geriatrics Society.

Figures

Figure 1.
Figure 1.
Prevalence (weighted to UK population structure 2011) of number of chronic diseases (of 18 in Table 1) by age group, from 2003–04 to 2011–12.

References

    1. Office for National Statistics. 2012. Population Ageing in the United Kingdom, its Constituent Countries and the European Union.
    1. Economist Intelligence Unit. London: 2012. A new vision for old age: rethinking health policy for Europe's Ageing Society: a report from the economist intelligence unit.
    1. Blunt I, Bardsley BM, Dixon J. Trends in Emergency Admissions in England 2004–2009. The Nuffield Trust; 2010. . (31 July 2014, date last accessed).
    1. Kaplan RM, Ong M. Rationale and public health implications of changing CHD risk factor definitions. Ann Rev Public Health. 2007;28:321–44.
    1. Mody L, Miller DK, McGloin JM, et al. Recruitment and retention of older adults in aging research. J Am Geriatr Soc. 2008;56:2340–48.
    1. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA. 2005;294:716–24.
    1. Connolly A, Gaehl E, Martin H, Morris J, Purandare N. Underdiagnosis of dementia in primary care: variations in the observed prevalence and comparisons to the expected prevalence. Aging Ment Health. 2011;15:978–84.
    1. Holman N, Forouhi N, Goyder E, Wild S. The Association of Public Health Observatories - diabetes prevalence model: estimates of total diabetes prevalence for England, 2010–2030. Diabet Med. 2011;28:575–82.
    1. Banerjee D, Chung S, Wong EC, Wang EJ, Stafford RS, Palaniappan LP. Underdiagnosis of hypertension using electronic health records. Am J Hypertens. 2011;25:97–102.
    1. Bowling CB, Muntner P. Epidemiology of chronic kidney disease among older adults: a focus on the oldest old. J Gerontol A Biol Sci Med Sci. 2012;67:1379–86.
    1. Schermer T, Smeele I, Thoonen B, et al. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J. 2008;32:945–52.
    1. Draisma G, Etzioni R, Tsodikov A, et al. Lead time and overdiagnosis in prostate-specific antigen screening: Importance of methods and context. J Natl Cancer Inst. 2009;101:374–83.
    1. Le Couteur DG, Doust J, Creasey H, Brayne C. Political drive to screen for pre-dementia: not evidence based and ignores the harms of diagnosis. BMJ. 2013;347:f5125.
    1. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ. 2012;344:e3502.
    1. Moynihan R, Glassock R, Doust J. Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased. BMJ. 2013;347:f4298.
    1. Martin Roland D. Linking physicians’ pay to the quality of care—a major experiment in the United Kingdom. N Engl J Med. 2004;351:1448–54.
    1. Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011;61:e12.
    1. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43.
    1. Primary Care Commissioning. The NHS Quality and Outcomes Framework for Primary Care: For earlier QOF Business rules contact (Accessed April 2012)
    1. Collerton J, Davies K, Jagger C, et al. Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ. 2009;399:b4904.
    1. Matthews FE, Arthur A, Barnes LE, et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the cognitive function and ageing study I and II. Lancet. 2013;382:1384–86.
    1. Kelfve S, Thorslund M, Lennartsson C. Sampling and non-response bias on health-outcomes in surveys of the oldest old. Eur J Ageing. 2013;10:237–45.
    1. Andersson M, Guo X, Börjesson-Hanson A, Liebetrau M, Östling S, Skoog I. A population-based study on dementia and stroke in 97 year olds. Age Ageing. 2012;41:529–33.
    1. Martinez C, Jones RW, Rietbrock S. Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study. BMJ Open. 2013;3:e002080.
    1. Kontopantelis E, Reeves D, Valderas JM, Campbell S, Doran T. Recorded quality of primary care for patients with diabetes in England before and after the introduction of a financial incentive scheme: a longitudinal observational study. BMJ Qual Safe. 2013;22:53–64.
    1. Brettell R, Soljak M, Cecil E, Cowie MR, Tuppin P, Majeed A. Reducing heart failure admission rates in England 2004–2011 are not related to changes in primary care quality: national observational study. Eur J Heart Fail. 2013;15:1335–42.
    1. National Collaborating Centre for Chronic Conditions. London: 2008. Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care. September.
    1. Crimmins EM, Beltrán-Sánchez H. Mortality and morbidity trends: Is there compression of morbidity? J Gerontol B Psychol Sci Soc Sci. 2011;66:75–86.
    1. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010;60:e128.
    1. Sheppard J, Singh S, Fletcher K, McManus R, Mant J. Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study. BMJ. 2012;345:e4535.
    1. Heath I. Overdiagnosis: when good intentions meet vested interests—an essay by Iona Heath. BMJ. 2013;347:f6361.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅